CE-SELEXEXSpyCas9aptamer

Ge Yang1, Huimin Wang2, Guangyu Jiang3

  • 1Key Laboratory of Molecular Medicine and Biotherapy, School of Life Science, Beijing Institute of Technology, 5 South Zhongguancun Street, Beijing, 100081, China; CAMS Key Laboratory of Antiviral Drug Research, Beijing Key Laboratory of Antimicrobial Agents, NHC Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.

Talanta
|March 13, 2024
PubMed
概括

研究人员开发了新型的体来抑制CRISPR-Cas9系统,提供了一个精确可控的基因编辑工具. 这些胺酶抑制剂克服了现有方法对增强CRISPR-Cas9活动控制的局限性.